Accession Number: | 0001104659-21-151738 |
Date: | 2021-12-16 |
Issuer: | IVERIC BIO, INC. (ISEE) |
Original Submission Date: |
DUGEL PRAVIN
C/O IVERIC BIO, INC.
5 PENN PLAZA, SUITE 2372
NEW YORK, NY 10001
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 14.83 | 2021-12-16 | deemed execution date | A | 100,000 (a) | 2031-12-16 | common stock 100,000 | $14.83 | 100,000 | direct | ||
RESTRICTED STOCK UNITS | 0.0 | 2021-12-16 | deemed execution date | A | 50,000 (a) | common stock 50,000 | $0.00 | 50,000 | direct |
ID | footnote |
---|---|
f1 | subject to continued employment with the registrant and the other terms and conditions under the registrant's 2013 stock incentive plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date. |
f2 | restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. |
f3 | subject to continued employment with the registrant and the other terms and conditions under the registrant's 2013 stock incentive plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on january 2, 2023, january 2, 2024, january 2, 2025 and january 2, 2026). |